Bristol-Myers Squibb Co.
Salud · USA
0
4.31%
Rentabilidad por dividendo
Creciente
Pagos regulares
Sin recortes de dividendos
Rentabilidad por dividendo moderada. El dividendo está creciendo.
Dividendo anual2,48 $
FrecuenciaTrimestral
Último dividendo
0,63 $
Fecha de pago1 de mayo de 2026
Fecha ex-dividendo2 de abril de 2026
Sobre la empresa
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.